KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Non-Current Assets: 2017-2025

Historic Other Non-Current Assets for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $4.9 million.

  • Twist Bioscience's Other Non-Current Assets rose 74.08% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 74.08%. This contributed to the annual value of $4.9 million for FY2025, which is 74.08% up from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Other Non-Current Assets is $4.9 million, which was up 74.08% from $2.8 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Other Non-Current Assets registered a high of $7.7 million during FY2021, and its lowest value of $2.8 million during FY2024.
  • Its 3-year average for Other Non-Current Assets is $4.5 million, with a median of $4.9 million in 2025.
  • As far as peak fluctuations go, Twist Bioscience's Other Non-Current Assets spiked by 171.84% in 2021, and later tumbled by 55.89% in 2022.
  • Twist Bioscience's Other Non-Current Assets (Yearly) stood at $7.7 million in 2021, then crashed by 55.89% to $3.4 million in 2022, then spiked by 67.83% to $5.7 million in 2023, then tumbled by 50.43% to $2.8 million in 2024, then spiked by 74.08% to $4.9 million in 2025.